February 22, 2022 – Proprio, the Seattle medical technology company enabling surgeons to perform complex procedures through the combination of computer vision, machine learning, and immersive technology, is pleased to announce the addition of Dr. Steven Glassman, MD as a Research Advisor.
The Medical Director at Norton Leatherman Spine Center in Louisville, KY, Dr. Glassman is also a Professor of Orthopaedic Surgery at the University of Louisville, Past-President of the Scoliosis Research Society, and Co-Chair of the American Spine Registry (ASR). Dr. Glassman has an extensive, published background on clinical outcomes and cost-effectiveness for lumbar spine surgery.
“Dr. Glassman is a true asset to our extended team as a research advisor,” noted Proprio CEO and Co-founder Gabriel Jones. “His expertise in developing successful clinical outcomes for orthopaedic and complex spine procedures is immensely beneficial to our team.”
“Proprio is on the cutting edge of designing truly innovative technology,” Dr. Glassman highlighted. “I look forward to supporting them as a research advisor by helping them transition data intelligence into opportunities that enable surgeons to achieve better clinical and economic outcomes.”
About Dr. Steven Glassman
Dr. Glassman completed his undergraduate and medical school training at Princeton University, New Jersey and the College of Physicians and Surgeons, Columbia University in New York. He completed his orthopaedic residency at Columbia Presbyterian Medical Center in New York followed by a Spine Fellowship at Leatherman Spine Fellowship Program in Louisville, Kentucky. He is the Medical Director at Norton Leatherman Spine Center, Professor of Orthopaedic Surgery at the University of Louisville, Past-President of the Scoliosis Research Society, and Co-Chair of the American Spine Registry (ASR).
Proprio is a medical technology company based in Seattle, Washington. We create the new way of seeing™ in surgery through a proprietary platform that synthesizes artificial intelligence, computer vision, augmented/virtual reality, and robotics. Proprio’s goal is to dramatically improve clinical and economic outcomes through the combination of physician expertise and immersive, intelligent technology. Proprio is backed by leading healthcare and technology investors, including DCVC (Data Collective), BOLD Capital Partners, Cota Capital, Intel, HTC, and Alan Frazier, founder of Frazier Healthcare Partners. For more information, visit www.propriovision.com.